Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction Using Uterine Artery Doppler, Maternal Blood Pressure, Maternal Characteristics, Placental Volume and Maternal Serum Factors

NCT02379494 is registered in ClinicalTrials.gov with Fetal Medicine Foundation as lead sponsor.

NCT NCT02379494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction Using Uterine Artery Doppler, Maternal Blood Pressure, Maternal Characteristics, Placental Volume and Maternal Serum Factors
Lead sponsor
Fetal Medicine Foundation
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
January 1, 2017
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction, preeclampsia